Conquest Research has filed a notice of an exempt offering of securities to raise $72,700,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Conquest Research is raising $72,700,000.00 in new funding. Sources indicate that as part of senior management President, Scott Snow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Conquest Research
Conquest Research was formed to offer the most efficient clinical research services to partners and pharmaceutical companies worldwide. With a leader who’s extremely passionate about advancing the clinical trial process through technology, our mission is to deliver high quality clinical research in a cost-effective and timely manner. Conquest Research offers services not only directly to pharmaceutical companies, but also to physician practices interested in conducting clinical trials to offer new and innovative treatment options to their patients.
To learn more about Conquest Research, visit http://conquestresearch.com/
Contact:
Scott Snow, President
407-916-0060
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.